Conventions: Feb 05, 2010
- AACR/JCA 8th Joint Conference: Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics
-
Feb 5, 2010 - Feb 9, 2010,
More than 20 years ago, the American Association for Cancer Research and the Japanese Cancer Association held their first of seven joint conferences. These meetings have been aimed at bringing outstanding American and Japanese researchers together with two goals. The first is to provide a forum for discussion of the latest advances in the broad field of cancer research, both translational/clinical and basic. The second and equally important goal is to provide a mechanism for the interpersonal interactions which foster international collaborations. These conferences have been extremely successful in both areas and are tangible examples of the close relationship between the AACR and the JCA.
The 8th Joint Conference continues to extend this tradition. The 13 conference sessions will feature outstanding speakers covering topics ranging from basic science to therapeutics, including prevention, epigenetics, and other important areas. Thus, the conference will take a broad view of contemporary cancer research that is intended to be of interest to basic and clinical investigators. The organization and timing of the platform and poster sessions have been designed to maximize interactions. The conference organizers believe that this meeting will catalyze many new collaborations, just as its predecessors have done.
ORGANIZING COMMITTEE:
AACR
José Baselga, Vall d'Hebron University Hospital, Barcelona, Spain
Sara A. Courtneidge, Burnham Institute for Medical Research, La Jolla, CA, USA
Carlo M. Croce, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
Daniel A. Haber, Massachusetts General Hospital, Charlestown, MA, USA
Tyler Jacks, MIT Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
Catriona H. M. Jamieson, UCSD Moores Cancer Center, La Jolla, CA, USA
Scott M. Lippman, UT M. D. Anderson Cancer Center, Houston, TX, USA
Jennifer A. Pietenpol, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
Geoffrey M. Wahl, Salk Institute Cancer Center, La Jolla, CA, USA
Louis M. Weiner, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA
JCA
Hideyuki Akaza, University of Tsukuba, Tsukuba, Japan
Hiroyasu Esumi, National Cancer Center Hospital East, Kashiwa, Japan
Okio Hino, Juntendo University School of Medicine, Tokyo, Japan
Setsuo Hirohashi, National Cancer Center, Tokyo, Japan
Kohzoh Imai, Sapporo Medical University, Sapporo, Japan
Fuyuki Ishikawa, Kyoto University, Kyoto, Japan
Yoshio Miki, Medical Research Institute, Tokyo, Japan
Kohei Miyazono, University of Tokyo, Tokyo, Japan
Morito Monden, Osaka University Medical School, Osaka, Japan
Hitoshi Nakagama, National Cancer Center Research Institute, Tokyo, Japan
Tetsuo Noda, JFCR-Cancer Institute, Tokyo, Japan
Nagahiro Saijo, National Cancer Center Hospital East, Chiba, Japan
Noriyuki Sato, Sapporo Medical University, Sapporo, Japan
Motoharu Seiki, University of Tokyo, Institute of Medical Science, Tokyo, Japan
Hiroshi Shiku, Mie University Graduate School of Medicine, Tsu Mie, Japan
Kazuo Tajima, Aichi Cancer Center Research Institute, Nagoya, Japan
Tadatsugu Taniguchi, University of Tokyo, Tokyo, Japan
Masae Tatematsu, Aichi Cancer Center Research Institute, Nagoya, Japan
Masazumi Tsuneyoshi, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Ryuzo Ueda, Nagoya City University Medical School, Nagoya, Japan
Keiji Wakabayashi, National Cancer Center Research Institute, Tokyo, Japan - full details
- 5a Conferenza Nazionale GIMBE® - Dall'Evidence-based Practice alla Clinical Governance
-
Feb 5, 2010 - Feb 5, 2010,
Royal Carlton Hotel Royal Hotel Carlton Bologna, Emilia Romagna Italy 40121GIMBE® organizza a Bologna il 5 febbraio 2010 la 5a Conferenza Nazionale: Dall'Evidence-based Practice alla Clinical Governance.
Due letture introduttive proveranno a rispondere a interrogativi di estrema attualità:
- Il Nuovo Sistema di Formazione Continua in Medicina rappresenta una concreta opportunità per la diffusione dell'EBP e l'attuazione della clinical governance nelle organizzazioni sanitarie? Attraverso quali strumenti è possibile raggiungere questi obiettivi?
- Il Governo Clinico costituisce un'ancora di salvezza per l'universalismo del sistema sanitario pubblico? In particolare, quali sono i rischi di una sua applicazione "federalistica" conseguente all'eterogeneità dei diversi Piani Sanitari Regionali?
La Sessione I è dedicata all'Evidence-based Practice: un percorso integrato di EBP nel corso di laurea in fisioterapia, qualità e affidabilità delle fonti d'informazione online da utilizzare "a leto del malato", come produrre raccomandazioni cliniche in assenza di evidenze.
Le sessioni successive metteranno in vetrina qualificati progetti di Clinical Governance realizzati nelle Aziende sanitarie:
- Sessione II: produzione di percorsi assistenziali e loro misurazione tramite audit clinici
- Sessione III: progetti di risk management
- Sessione IV: sperimentazioni di strategie e interventi organizzativi
Appuntamento a Bologna! - full details
